Cleared Traditional

K822219 - HUMAN PLASMA CONTROL FOR CEA-ROCHE

K822219 is an FDA 510(k) clearance for HUMAN PLASMA CONTROL FOR CEA-ROCHE, manufactured by Hoffmann-La Roche, Inc.. The device is a Class 1 Immunology device with product code JJX cleared through the Traditional 510(k) pathway after a 155-day FDA review.

K822219 · Hoffmann-La Roche, Inc. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1982
Decision
155d
Days
Class 1
Risk

K822219 is an FDA 510(k) clearance for the HUMAN PLASMA CONTROL FOR CEA-ROCHE. Classified as Single (specified) Analyte Controls (assayed And Unassayed) (product code JJX), Class I - General Controls.

Submitted by Hoffmann-La Roche, Inc. (Walker, US). The FDA issued a Cleared decision on December 28, 1982 after a review of 155 days - an extended review cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 862.1660 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Immunology review framework, consistent with the majority of Class II 510(k) submissions.

View all Hoffmann-La Roche, Inc. devices

FDA 510(k) Submission Details - K822219

510(k) Number K822219 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 26, 1982
Decision Date December 28, 1982
Days to Decision 155 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
50d slower than avg
Panel avg: 105d · This submission: 155d
Pathway characteristics
Predicate-based equivalence.

JJX Device Classification - Class 1, General Controls

Product Code JJX Single (specified) Analyte Controls (assayed And Unassayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJX Single (specified) Analyte Controls (assayed And Unassayed)

All 453
Devices cleared under the same product code (JJX) and FDA review panel - the closest regulatory comparables to K822219.
PHADEBAS HUMYLASE CONTROL(H)
K823421 · Pharmacia, Inc. · Apr 1983
DAC-CEL DIAGNATAL HCG STANDARDS RD49
K830204 · Wellcome Diagnostics · Feb 1983
BIO INTERFERENCE BLANKING MATERIAL
K823687 · American Monitor Corp. · Jan 1983
PHADEBASE HUMYLASE CONTROL
K822938 · Pharmacia, Inc. · Nov 1982
GLUCOSCAN CONTROLS
K822698 · Lifescan, Inc. · Sep 1982
POSITIVE & NEGATIVE HCG URINE CONTROLS
K821742 · Armkel, LLC · Jul 1982